Barclays maintains an 'Overweight' on Iconix Brand (ICON); Cutting Numbers As Challenges Mount
Tweet
Share
E-mailGet Alerts ICON Hot Sheet
Price: $3.15 --0%
Rating Summary:
2 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
2 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Iconix Brand (NASDAQ: ICON) price target slashed from $27 to $20.
Analyst, Robert S. Drbul, said, "Revenue declined 4.2% to $88.5 million, pressured by the transition of Royal Velvet to a new DTR license with J.C. Penney (NYSE: JCP) and continued softness in the men's brands, particularly Rocawear and Ecko...Ecko was most pressured in the footwear business, licensed by Skechers (NYSE: SKX)...Given challenges and transitions within the portfolio, we view 2012 conservatively and are lowering our 2012 and 2013 EPS estimates to $1.70 and $1.95, from $1.80 and $2.00, respectively, which now include the impact of buybacks."
For an analyst ratings summary and ratings history on Iconix Brand click here. For more ratings news on Iconix Brand click here.
Shares of Iconix Brand closed at $14.53 yesterday.
Analyst, Robert S. Drbul, said, "Revenue declined 4.2% to $88.5 million, pressured by the transition of Royal Velvet to a new DTR license with J.C. Penney (NYSE: JCP) and continued softness in the men's brands, particularly Rocawear and Ecko...Ecko was most pressured in the footwear business, licensed by Skechers (NYSE: SKX)...Given challenges and transitions within the portfolio, we view 2012 conservatively and are lowering our 2012 and 2013 EPS estimates to $1.70 and $1.95, from $1.80 and $2.00, respectively, which now include the impact of buybacks."
For an analyst ratings summary and ratings history on Iconix Brand click here. For more ratings news on Iconix Brand click here.
Shares of Iconix Brand closed at $14.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Goldman Sachs Upgrades Bank Central Asia Tbk (BBCA:IJ) (PBCRY) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
